TheraB Medical Secures Additional Strategic Investment From Foster Lane Investments, LLC
April 10, 2024- TheraB Medical, a leading medical technology company specializing in neonatal care solutions, is thrilled to announce that they have secured additional investment in their Seed fundraising round from Foster Lane Investments, LLC. With this investment, TheraB has successfully closed 80% of their current Seed funding round.
With support from prominent investors such as Foster Lane, TheraB is positioned to commercialize their flagship product, SnugLit, by early 2025.
“We are thrilled to support this amazing company,” said Kathleen R. Hay, Investment Manager for Foster Lane Investments, LLC. “Alexa and the TheraB team will demonstrate a huge positive impact for newborns and their mothers with SnugLit.”
With the unwavering support of existing and recent investors, TheraB Medical remains committed to delivering innovative medical devices that enhance neonatal health while improving the healing experience for mom and baby.
For more information about TheraB Medical please visit www.therabmedical.com
-------------------------------------------------
About TheraB Medical:
TheraB Medical is a medical technology company focused on improving neonatal care. The company's flagship product, SnugLit, is a portable and wearable phototherapy device designed for the treatment of infant jaundice. TheraB Medical is dedicated to enhancing the health and well-being of infants and children through innovative medical devices.
Contact:
Alexa Jones, CEO, TheraB Medical
Alexa.jones@therabmedical.com